Suppressing effects of down-regulating DNMT1 and DNMT3b expression on the growth of human cholangiocarcinoma cell line

Abstract

Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.

Keywords

DNA methyltransferase 1 / DNA methyltransferase 36 / cholangiocarcinma / antisense / apoptosis

References

[1] DasP. M., SingalR.. DNA methylation and cancer. J Clin Oncol, 2004, 22(22): 4632

[2] EggerG., LiangG., AparicioA., et al.. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004, 429(6990): 457

[3] BallestarE., EstellerM.. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis, 2002, 23(7): 1103

[4] HermannA., GowherH., JeltschA.. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci, 2004, 61(19–20): 2571

[5] TangQ. B., SunH. W., ZouS. Q.. 5-aza-2-deoxycytidine inhibits the growth of bile duct cancer cell line in vivo and in vitro. Chin J Gen Surg, 2004, 19(5): 295

[6] TangQ. B., SunH. W., ZouS. Q.. Effects of 5-aza-2-deoxycytidine on the growth and apoptosis of bile duct cancer cell line. J Huazhong Univ Sci Tech (Health Sci), 2004, 33(1): 34

[7] VertinoP. M., YenR. W., GaoJ., et al.. De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA(cytosine-5)-methyltransferase. Mol Cell Biol, 1996, 16(8): 4555

[8] LuR., FangJ. Y., ZhuH. Y., et al.. Effect of recombinant DNA methylferase 1 plasmid on the expression of tumor associated gene in human colon cancer cell line. Chin J Dig, 2004, 24(2): 67

[9] RheeI., BachmanK. E., ParkB. H., et al.. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 2002, 416(6880): 552

[10] LeuY. W., RahmatpanahF., ShiH., et al.. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res, 2003, 63(19): 6110

[11] XuX. L., YuJ., ZhangH. Y.. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis, 2004, 10(23): 3441

[12] CurtisC. D., GogginsM.. DNA methylation analysis in human cancer. Methods Mol Med, 2004, 103: 123

[13] TozawaT., TamuraG., HondaT., et al.. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Cancer Sci, 2004, 95(9): 736

[14] LindG. E., ThorstensenL., LovigT., et al.. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer, 2004, 3: 28

[15] MizunoS., ChijiwaT., OkamuraT., et al.. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood, 2001, 97(5): 1172

[16] RobertsonK. D., UzvolgyiE., LiangG., et al.. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res, 1999, 27(11): 2291

[17] RobertM. F., MorinS., BeaulieuN., et al.. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet, 2003, 33(1): 61

[18] FangJ. Y., YangL., ZhuH. Y., et al.. 5-Aza-2′-deoxycitydine induces demethylation and up-regulates transcription of p16INK4A gene in human gastric cancer cell lines. Chin Med J (Engl), 2004, 117(1): 99

[19] BrownR., PlumbJ. A.. Demethylation of DNA by decitabine in cancer chemotherapy. Expert Rev Anticancer Ther, 2004, 4(4): 501

[20] DaskalakisM., NguyenT. T., NguyenC., et al.. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood, 2002, 100(8): 2957